Financials
Financial year 2025
Genome Group from Ukkel, company number BE1025801526, closed financial year 2025 with a result of € 23,312 after tax. For that financial year Genome Group recorded a gross margin of € 31,951 and equity of € 15,500. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.
€ 15,500
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 23,312
Profit after tax over the fiscal year.
€ 26,467
Cash and bank balances on the last day of the fiscal year.
€ 10,811 paid out
46 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 1,158
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,152
Supplier invoices still open on the last day of the fiscal year.
€ 18,109
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to Genome Group?
What happened at Genome Group in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 23,312. Source: NBB ↗
- New establishment in Ukkel. KBO
- Arnaud Leclercq became a director. NBB
- Start of the company according to the CBE. KBO
In short
Paid € 8,125 in corporate taxes since 2025.
Paid out € 10,811 in dividends to the owners in total.
A new publication or filing at Genome Group? We notify you, reason included.
Follow Genome GroupDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Genome Group is Arnaud Leclercq. Arnaud Leclercq is also behind FOLIES BOURGEOISES.
Directors
According to the 2025 annual accounts
since 2025
Establishments
Establishment units
Physical locations of this company
Onderlinge Bijstandstraat 61
1180 Ukkel
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1025.801.526
- VAT number
- BE 1025.801.526
- Registered office
- Onderlinge Bijstandstraat 61, 1180 Ukkel
- Names & denominations
- Genome Group
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 23 July 2025
- Peppol
- Active · Active since 8 Jan 2026
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van public relations en communicatie
Overige ondersteunende activiteiten in verband met financiële diensten, neg, exclusief verzekeringen en pensioenfondsen
Promotie en organisatie van scheppende en uitvoerende kunstevenementen
Organisatie van congressen en beurzen
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies